PhaseBio Pharmaceuticals Inc. (PHAS) dipped -7.47% or -0.22 to $2.78. It is near to 12038 shares traded, which is 76.12% compare to the average total volume 15814. The market cap of PHAS is $68.01 million. The year to date change is -11.77%. The 52 week price range is from $2.55 to $6.0. Price of PHAS have changed -1.64% during last week. It have changed -5.36% over last month, -18.26% over last 3 months, -40.00% over last 6 months and -40.00% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PHAS is 3.29. It is 18.35% above current price. The 52-week High is 6.0. It is 115.83% from the current price. The 52-week Low is 2.55. It is -8.27% from current price.
There are some statistics of PHAS. It is has market cap $68.01 million. The share outstanding is 24.50 million. The average volume is 15814. The percent of top 15 Institution holding is 21.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PHAS is 17.05%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PHAS is -72.08%.